miR-137 |
c-Met, CDK6, MITF, p160 SRCs |
Down |
Inhibit cell proliferation |
Cell lines (M17, M23, SP6.5, OCM-1/3, OMM1/1.3, Mel202, 92.1) |
Tumor suppressor |
19,20
|
miR-145 |
IRS-1 |
Down |
Inhibit cell proliferation and promote apoptosis |
Tissues and cell lines (OCM-1, MUM-2B) |
Tumor suppressor |
21 |
miR-144 |
c-Met |
Down |
Inhibit cell proliferation and invasion |
Tissues and cell lines (OCM-1A, MUM-2B/2C, C918) |
Tumor suppressor |
22 |
miR-92a-3p |
MYCBP2 |
Up |
Inhibit apoptosis |
Cell lines (OCM-1/3, 92.1) |
Oncogenic |
23 |
miR-181b |
CTDSPL |
Up |
Promote cell cycle progression |
Tissues and cell lines (SP6.5, VUP, OCM-1/1A, MUM-2B, 92.1) |
Oncogenic |
24 |
miR-296-3p |
MMP-2, MMP-9 |
Down |
Inhibit cell proliferation, migration, invasion and promote apoptosis |
Tissues and cell lines (C918) |
Tumor suppressor |
25 |
miR-20a |
Not reported |
Up |
Promote cell proliferation, migration and invasion |
Tissues and cell lines (MUM-2B/2C) |
Oncogenic |
26 |
miR-155 |
NDFIP1 |
Up |
Promote cell proliferation and invasion |
Tissues and cell lines (OCM-1A, MUM-2B/2C, C918) |
Oncogenic |
27 |
miR-454 |
PTEN |
Up |
Promote cell proliferation, invasion, colony formation and cell cycle progression |
Tissues and cell lines (OCM-1A, MUM-2B/2C, C918) |
Oncogenic |
28 |
miR-367 |
PTEN |
Up |
Promote cell proliferation and migration |
Tissues and cell lines (M17/23, MUM-2B, C918) |
Oncogenic |
29 |
miR‐224‐5p |
PIK3R3/AKT3 |
Down |
Inhibit cell proliferation, migration and invasion |
Tissues and cell lines (OCM-1A) |
Tumor suppressor |
30 |
miR-21 |
p53 |
Up |
Promote cell proliferation, migration and invasion |
In vivo (BALB/c) and cell lines (OCM-1A) |
Oncogenic |
31 |
miR-23a |
Zeb1 |
Down |
Inhibit cell migration |
Cell lines (OCM-1) |
Tumor suppressor |
34 |